SuperworthSANUWAVE Health profit margin SNWV
Gross, operating and net profit as a share of revenue over the last twelve months, from 2022.
- Net margin, 12 months
- 36.0%
- Operating margin, 12 months
- 4.7%
- Net margin on a year earlier
- +135.7 pts
- Peer median
- 8.4%
Over the twelve months to Jun 30, 2026, SANUWAVE Health kept 36.0% of its revenue as net profit, with an operating margin of 4.7% and a gross margin of 76.4%.
The median for 7 medical instruments and supplies stocks of a similar size is 8.4%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | 28.1% | 12.5% | 77.2% |
| FY2024 | −96.1% | 16.6% | 75.2% |
| FY2023 | n/a | −2.6% | 70.4% |
| FY2022 | −61.5% | −53.5% | 74.1% |
| FY2021 | n/a | n/a | 61.7% |
| FY2020 | n/a | n/a | 71.4% |
| FY2019 | n/a | n/a | n/a |
| FY2018 | n/a | n/a | 62.5% |
| FY2017 | n/a | n/a | 67.2% |
| FY2016 | n/a | n/a | 58.9% |
| FY2015 | n/a | n/a | 70.5% |
| FY2014 | n/a | n/a | 74.0% |
| FY2013 | n/a | n/a | 76.3% |
| FY2012 | n/a | n/a | 71.4% |
| FY2011 | n/a | n/a | 67.4% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | 36.0% | +135.7 pts | 4.7% | |
| Q1 FY26 | 38.5% | +129.6 pts | 8.5% | |
| Q4 FY25 | 28.1% | +124.3 pts | 12.5% | |
| Q3 FY25 | −19.4% | −18.1 pts | 14.6% | |
| Q2 FY25 | −99.7% | −86.0 pts | 16.7% | |
| Q1 FY25 | −91.1% | −14.1 pts | 19.5% | |
| Q4 FY24 | −96.1% | n/a | 16.6% | |
| Q3 FY24 | −1.3% | n/a | 13.4% | |
| Q2 FY24 | −13.8% | n/a | 5.8% | |
| Q1 FY24 | −77.0% | n/a | 1.7% | |
| Q4 FY23 | n/a | n/a | −2.6% | |
| Q3 FY23 | n/a | n/a | −16.1% |
Against its peers
Companies in Medical - Instruments & Supplies nearest SANUWAVE Health's size, closest first, today.
| Company | Profit margin |
|---|---|
| SNWVSANUWAVE Health | 36.0% |
| NEPHNephros | 8.4% |
| APTAlpha Pro Tech | 6.8% |
| KEQUKewaunee Scientific | 3.0% |
| PDEXPro DEX | 17.6% |
| UTMDUtah Medical Products | 29.0% |
| INFUInfuSystem | 6.0% |
| EMBCEmbecta | 8.6% |
| Peer median | 8.4% |
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on SANUWAVE Health
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.